166271-28-9

Basic information

• Product Name: H-PRA-OME HCL
• Synonyms: L-PROPARGYL-GLY-OME HCL;L-PROPARGYLGLYCINE METHYL ESTER HYDROCHLORIDE;H-PROPARGYL-GLYCINE-OME HCL;H-PROPARGYL-GLY-OME HCL;H-PRA-OME HCL;(S)-PROPARGYLGLYCINE METHYL ESTER HYDROCHLORIDE;(S)-PROPARGYLGYYCINE METHYL ESTER;H-Propargyl-Gly-OMe · HCl, (S)-2-AMino-4-pentynoic acid-Methyl ester · HCl
• CAS NO: 166271-28-9
• Molecular Formula: C6H10ClNO2
• Molecular Weight: 163.6
• Mol File: 166271-28-9.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: H-PRA-OME HCL(CAS DataBase Reference)
• NIST Chemistry Reference: H-PRA-OME HCL(166271-28-9)
• EPA Substance Registry System: H-PRA-OME HCL(166271-28-9)

Safety Data

• Hazardous Substances Data: 166271-28-9(Hazardous Substances Data)

Usage

Chemical Properties

White powder

Upstream product

• 67-56-1 methanol 
• 23235-01-0 (R)-2-aminopent-4-ynoic acid 

Downstream Products

• 1423324-26-8 (S)-methyl 2-((S)-2-((tert-butoxycarbonyl)-amino)-5-methoxy-5-oxopentanamido)pent-4-ynoate 
• 1364222-47-8 C₃₀H₃₃N₉O₈ 
• 71460-02-1 methyl (2S)-2-(tert-butoxycarbonylamino)pent-4-ynoate 

Relevant articles and documents

CARBORANE HYDROXAMIC ACID MATRIX METALLOPROTEINASE AGENTS FOR BORON NEUTRON CAPTURE THERAPY

Disclosed herein are novel carborane hydroxamic acid matrix metalloproteinase ("MMP") agents bearing borane-containing moieties and methods for their use in treating or preventing a disease, such as cancer and rheumatoid arthritis. In particular, disclosed herein are compounds of Formula (I) and (II) and pharmaceutically acceptable salt thereof: wherein the substituents are as described.